Article,
Innovative approaches in characterizing and developing methods for lipoidal vesicular drug delivery systems
GSC Advanced Research and Reviews, 20 (1): 427–438 (September 2024)
DOI: 10.30574/gscarr.2024.20.1.0278
Abstract
Lipoidal vesicular systems, including liposomes, ethosomes, and transferosomes, represent a significant advancement in targeted drug delivery, offering enhanced bioavailability, controlled release, and specific targeting capabilities. This review discusses the types of lipoidal vesicular systems, their methods of characterization, method development, applications, advantages, challenges, and future perspectives. These systems have shown immense potential in diverse therapeutic areas, including cancer therapy, infectious diseases, gene therapy, and transdermal drug delivery. Despite the challenges in stability, scalability, and targeting, ongoing research and technological advancements promise to expand their applications and improve therapeutic outcomes.
